When you hear someone has "gone live" you might think of Facebook live or Instagram live. However, for nearly 40 million people, they think of the platform they use on a regular basis: Live.me. The platform lets broadcasters interact directly with fans as they produce content. Then, those fans can pay their favorite creators with digital gifts that are turned into real currency.
Kjudor Annous, head of marketing and partnerships at Live.me, joins Cheddar to explain how the platform is pushing live video forward. By giving viewers the options to pay their favorite creators, both parties have the incentive to go on the platform, and to engage with it.
For the future, Annous says that Live.me is interested in pursuing partnerships. They are excited about growth, and hope to continue adding to their user base.
Mortgage rates have dropped below 7% for the first time since the middle of August.
Taylor Swift grossed nearly $2 billion this year, according to Billboard.
A study from US News and World Report has found the most affordable place to retire is in Ohio.
Millions of households could see higher internet costs next year as the affordable connectivity program could end.
Viveca Chow, NYC lifestyle expert, spoke with Cheddar News to provide tips on how to have some festive fun in the city on a budget.
Apple announced that it's releasing an iPhone security update to prevent attackers from acquiring users' private passcodes.
As the new year approaches, many people are looking to find a job with a higher salary or are planning to ask their current boss for a raise. Taliya Bashani, real estate attorney and negotiation expert, joined Cheddar News to provide tips on how to properly and better negotiate better financial terms.
Meta says it will start testing a program that would allow posts from Threads to appear on other social media sites.
Several healthcare companies are reportedly joining President Biden's artificial intelligence risk management plan.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
